Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.58 |
| ▸ | MAPT | P10636 | 5/20 | 0.58 |
| ▸ | MITF | O75030 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 5/20 | 0.57 |
| ▸ | RAB9A | P51151 | 5/20 | 0.57 |
| ▸ | POLB | P06746 | 5/20 | 0.57 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | CASP1 | P29466 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30137706 | 1.00 | MEN1 (0.58) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL28466533 | 0.86 | KDM4E (0.57) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL1667141 | 0.82 | KDM4E (0.53) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL16355668 | 0.80 | CYP2A6 (0.55) | MEN1KMT2ATDP1NPC1RAB9A | |
| Acetamide SCHEMBL10951863 | 0.80 | IDO1 (0.56) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL6460 | 0.80 | GRIN2D (0.66) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL27593821 | 0.80 | MEN1 (0.60) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL29358330 | 0.80 | GRIN2D (0.66) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL6697937 | 0.78 | GRIN2D (0.63) | MEN1KMT2AMAPTMITFGAA | |
| SCHEMBL11268428 | 0.78 | IDO1 (0.59) | MAPTPOLBKDM4ECA9MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365851-A1 | THERMALLY CONDUCTIVE ADDITIVE, THERMALLY CONDUCTIVE COMPOSITE MATERIAL, AND WIRE HARNESS | AUTONETWORKS TECHNOLOGIES, LTD. (JP) | 2023-11-16 | — | — | US | disclosed |
| US-20230365851-A1 | THERMALLY CONDUCTIVE ADDITIVE, THERMALLY CONDUCTIVE COMPOSITE MATERIAL, AND WIRE HARNESS | AUTONETWORKS TECHNOLOGIES, LTD. (JP) | 2023-11-16 | — | — | US | disclosed |
| CN-115475249-A | Photoresponse carbon monoxide release nanogel and preparation method and application thereof | 西北工业大学 | 2022-12-16 | — | — | CN | disclosed |
| US-20220119376-A1 | TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| EP-3848367-A1 | TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2021-07-14 | — | — | EP | disclosed |
| WO-2020132603-A2 | SALICYL-ADENOSINEMONOSULFAMATE ANALOGS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2020-06-25 | — | — | WO | disclosed |
| US-9840488-B2 | Carbon monoxide releasing molecules and associated methods | UTAH STATE UNIVERSITY (US) | 2017-12-12 | — | — | US | disclosed |
| US-9840488-B2 | Carbon monoxide releasing molecules and associated methods | UTAH STATE UNIVERSITY (US) | 2017-12-12 | — | — | US | disclosed |
| US-9840488-B2 | Carbon monoxide releasing molecules and associated methods | UTAH STATE UNIVERSITY (US) | 2017-12-12 | — | — | US | disclosed |
| EP-2290015-B1 | NANOSCALE PIGMENT PARTICLE COMPOSITION AND PROCESS FOR PRODUCING THE SAME | XEROX CORP (US) | 2017-05-24 | — | — | EP | disclosed |
| US-20060111375-A1 | Compound having tgfß inhibitory activity and medicinal composition containing the same | KIRIN BEER KABUSHIKI KAISHA (JP) | 2006-05-25 | — | — | US | disclosed |
| EP-1548008-A1 | COMPOUND HAVING TGF-BETA INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME | KIRIN BEER KABUSHIKI KAISHA (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-5855661-A | METALLO, MONO AND BI-DENTATE LIGAND PIGMENT PARTICLES WITH A SURFACE DERIVATIZING AGENT HAVING ONE OR MORE PHENOLIC MOIETIES, A 1, 3-DIKETO MOIETY OR A COMBINATION THEREOF. | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| US-5849074-A | Method for preparing magnetic ink and dry pigment particles used therefor | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1998-12-15 | — | — | US | disclosed |
| EP-0876432-A1 | METHOD FOR PREPARING MODIFIED MAGNETIC PIGMENT PARTICLES | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1998-11-11 | — | — | EP | disclosed |
| US-5645768-A | PYRAN IN WHICH AROMATIC RESIDUES ARE RIGIDLY ATTACHED TO A SPIROPYRAN; TINTING OPTICAL PLASTIC MATERIAL | OPTISCHE WERKE G. RODENSTOCK (DE) | 1997-07-08 | — | — | US | disclosed |
| WO-1997012941-A1 | METHOD FOR PREPARING MODIFIED MAGNETIC PIGMENT PARTICLES | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1997-04-10 | — | — | WO | disclosed |
| EP-0010842-B1 | POLYURETHANE FOAM AND METHOD OF PREPARATION THEREOF | UNIROYAL LTD. (CA) | 1983-09-21 | — | — | EP | disclosed |
| US-4209593-A | Semi-flexible shock-absorbing polyurethane foam prepared from a triol, a compound having a single reactive hydrogen, an aromatic polyisocyanate, blowing agent, chain-extender and a catalyst | UNIROYAL LTD. (CA) | 1980-06-24 | — | — | US | disclosed |
| EP-0010842-A1 | Polyurethane foam and method of preparation thereof | UNIROYAL LTD. (CA) | 1980-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119376-A1 | TRICYCLIC COMPOUNDS ACTING ON CRBN PROTEINS | CRBN, CSNK2A1, CSNK2A2 | MEN1 3379/4885KMT2A 2165/4885MAPT 539/4885 |
| US-20060111375-A1 | Compound having tgfß inhibitory activity and medicinal composition containing the same | TGFB1, TGFBR1, TGFBR2 | MEN1 1660/4885KMT2A 2521/4885MAPT 2587/4885 |
| US-20230365851-A1 | THERMALLY CONDUCTIVE ADDITIVE, THERMALLY CONDUCTIVE COMPOSITE MATERIAL, AND WIRE HARNESS | ILK, TPR, PIEZO1 | MEN1 871/4885KMT2A 2539/4885MAPT 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.